Indivior Pharmaceuticals, Inc. INDV Business Segments — Interest Expense

Similar metrics at other companies

SNOWReportable Segment — Interest Expense

-$2.08M-0.4%

MRVLReportable Segment — Interest Expense

$52.8M+8.4%

OLP

OLPXReportable Segment — Interest Expense

$7.13M-48.0%

NCNOReportable Segment — Interest Expense

$4.48M+0.7%

NSA

NSAReportable Segment — Interest Expense

$39.26M-3.0%

LMNDReportable Segment — Interest Expense

$6.2M+87.9%

FAQ

What is Indivior Pharmaceuticals, Inc.'s business segments — interest expense?

Indivior Pharmaceuticals, Inc. (INDV) reported business segments — interest expense of $7M in Q1 2026.

How has Indivior Pharmaceuticals, Inc.'s business segments — interest expense changed year-over-year?

Indivior Pharmaceuticals, Inc.'s business segments — interest expense decreased by 41.7% year-over-year, from $12M to $7M.

What is the long-term trend for Indivior Pharmaceuticals, Inc.'s business segments — interest expense?

Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s business segments — interest expense has grown at a 18.6% compound annual growth rate (CAGR), from $27M to $45M.

What does business segments — interest expense mean?

Represents the cost of debt financing incurred by the segment, including interest on loans and other financial obligations. This metric is vital for evaluating the segment's leverage and the impact of financing costs on overall profitability.